EP3215844
METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS' RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS)
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.8.2015EP published:
28.4.2021EP application number:
15794313.5
EPO information:
European Patent Register
Max expiry date:
18.8.2035
Title:
METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS' RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS)
Timeline
Today
19.8.2015EP application
28.4.2021EP Publication
Owner
Name:
Yissum Research Development Company of the Hebrew University of Jerusalem LtdAddress:
Hi Tech Park Edmond J. Safra Campus Givat Ram, 9139002 Jerusalem, IL
Name:
Hadasit Medical Research Services and Development Ltd.Address:
Kiryat Hadassah P.O. Box 12000, 9112001 Jerusalem, IL
Inventor
Name:
BANIYASH, MichalAddress:
9075804 Mevasseret Zion, IL
Name:
LOTEM, MichalAddress:
7179902 Makabim-Re'ut, IL
Name:
SADE-FELDMAN, MosheAddress:
7172129 Modiin, IL
Name:
KANTERMAN, JuliaAddress:
7172129 Modiin, IL
Priority
Number:
201462039156 PDate:
19.8.2014Country:
US
Number:
201462079018 PDate:
13.11.2014Country:
US
Classification
Categories:
G01N 33/50, G01N 33/574